Saudi Press

Saudi Arabia and the world
Tuesday, Apr 07, 2026

AstraZeneca vaccine: How do you weigh up the risks and benefits?

AstraZeneca vaccine: How do you weigh up the risks and benefits?

For most people currently being offered the Oxford-AstraZeneca vaccine, the benefits clearly outweigh the risks.

But the UK's Joint Committee on Vaccination and Immunisation (JCVI) has recommended that - because of an "extremely small" number of cases of blood clots in some who have had the jab - people under 30 should be offered other vaccines.

Everyone's choice is different - weighing up the risk of potential side effects against the chance of contracting coronavirus and perhaps becoming seriously ill, or even dying.

We don't know enough to be able to plug the data into a calculator and get a simple, exact answer tailored to you.

But here's the best information we currently have on the possible risks and benefits.

The events are so rare, we need to start off with a huge number of people to make sense of them.

So, let's take a figure of 10 million imaginary people.

What are the risks of blood clots with the AZ vaccine?


Regulators are continuously combing through the details of the rare clots that have occurred to work out how many might be caused by vaccination.

Assuming the worst - that they all are - we can do some ballpark calculations to get a sense of the risks.

Based on the figures announced today by the UK medicines regulator, if 10 million imaginary people were given the AZ vaccine you might expect to see 40 of these clots - with about 10 clots having fatal consequences.

Ten deaths out of 10 million people vaccinated is a one-in-a-million chance.

That's roughly the same risk as being murdered in the next month or - if you get in a car and drive for 250 miles - the risk of you dying in a road accident on that journey.


How does that compare to the normal risk of these clots?


Roughly 40 men and 100 women in our imaginary group of 10 million might expect to have one of these clots in any given year without vaccination, with more seen in younger people.

That's about 12 a month - so seeing a larger number in just a few weeks after vaccination is part of the picture of higher risk.

One review of this condition says that about three-quarters of those people would go on to make a good recovery, but a small number, say one or two people, might die within a month of the clot.

The European medicines regulator has said that by mid-March, they might have expected to see between one and two cases of this clot in people under 50 given the vaccine, but they had seen 12 - about nine times higher than they would expect.

How does that compare to the risks of clots from the pill?


These clots happen more often to pregnant women or people taking female hormones.

In general, if you're on the pill the risk is about six times higher than if you're not.

So the risks of a clot for those taking a contraceptive pill seem, at first glance, to be in a similar ballpark to the risks potentially linked to the AZ vaccine, but we can't know for sure with the data we have.

To be really sure, we would need to compare them directly in a single study.

And whether or not you take a medicine depends on the benefits, as well as the risk.

What are the benefits of taking the vaccine?


If you delayed vaccinations for our 10 million people by a week, about 16,000 might catch coronavirus, based on current levels of the virus.

If they were all older adults, say 60-year-olds, maybe 1,000 would end up in hospital and 300 of them might be expected to die, far more than the 10 deaths from clots after vaccination that we mentioned earlier.

But for younger adults the risks of hospitalisation or death are considerably lower.

Given the same number of infected 40-year-olds, 16 might be expected to die. And the number of expected fatalities would be even lower for people in their 20s and 30s.

So for younger age groups the choice over whether to have the AZ vaccine is not as clear cut, especially when there are so many uncertainties in all these figures.

But death isn't the only issue. About a quarter of people who end up in intensive care with Covid have some form of clot resulting from the virus.

And long Covid is more likely to affect 30-year-olds than 70-year-olds. On average, just over 2,000 of our group would still be dealing with Covid symptoms three months later, and more than half of them would be limited in their daily activities by those symptoms.

While there's no simple number for everyone, for most people with a high risk of catching Covid or dying from Covid, the current data suggests very strongly "your chances of remaining alive and well will go up if you take the vaccine and will go down if you don't" as JCVI member Adam Finn explains.

But it does change for younger people.

England's Chief Medical Officer Prof Chris Whitty says: "The closer you get to someone who's right down at 20, and otherwise blameless in their health, the more you have to think through these really very rare side effects - the risk/benefits might get closer to parity."

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Taiwan to Source Oil Shipments from Saudi Arabia’s Red Sea Ports
Saudi Arabia Evacuates Riyadh Financial District as Precaution Amid Regional Tensions
Saudi Arabia Balances Ambitious Economic Vision Amid Regional Tensions and Financial Pressures
Budget Saudi Arabia Reports Strong Full-Year 2025 Financial Performance
Saudi Arabia Expands Investment in Capcom With Stake Reaching Six Percent
Saudi Arabia Assesses Significant Economic Impact From Regional Conflict Involving Iran
US Beef Secures Expanded Market Access in Saudi Arabia
Jordan and Saudi Arabia Declare Absolute Solidarity in Response to Iranian Threats
Saudi Arabia Raises Oil Prices to Record Premium Amid Strong Market Demand
California’s Salton Sea Emerges as Strategic Lithium Hub for Clean Energy Future
Iranian Drone Strike on US Embassy in Saudi Arabia Reportedly Targeted Intelligence Facility
Saudi Deputy Foreign Minister Meets French Embassy Official to Strengthen Bilateral Engagement
Saudi Arabia Calls on United States to Seize Strategic Opportunity to Reshape Middle East
Dating Apps Surge in Saudi Arabia as Social Norms Rapidly Evolve Among Youth
Saudi Arabia Detains Over Fourteen Thousand Illegal Residents in Week-Long Enforcement Drive
Saudi Foreign Minister Engages in Diplomatic Talks with Pakistan, Kuwait and Latvia on Regional Developments
Saudi Arabia Intercepts Cruise Missile as Regional Tensions Intensify
Saudi Stock Market Edges Higher as Tadawul Index Records Modest Gain
Underlying Rivalry Between Saudi Arabia and UAE Persists Despite Temporary Calm
Saudi Arabia’s Non-Oil Sector Contracts in March as Regional Tensions Weigh on Business Activity
Saudi Arabia Unveils Ambition to Establish Prestigious Global Prize Rivaling the Nobel
Saudi Crown Prince to Engage Wall Street in Push for Investment and Economic Expansion
Iran Accuses Saudi Arabia and UAE After Downing of Chinese-Made Drone
Saudi Arabia Condemns Attack on Hospital in Sudan, Calls for Protection of Civilians
Coordinated Drone Strike Targets CIA Facility Within US Embassy in Saudi Arabia
Italy’s Meloni Prioritises Energy Security and Strait of Hormuz Stability During Gulf Tour
Uncertainty Emerges Over Timeline and Direction of Saudi Arabia’s Ambitious Ski Resort Project
UAE and Saudi Arabia Escalate Strategy with Drone Operations Targeting Iran
Trump Delivers Characteristic Remarks on Saudi Crown Prince Amid Intensifying Iran Conflict
Drone Strike on US Embassy in Riyadh Caused Greater Damage Than First Reported
Saudi Arabia Introduces Flexible Solutions for Expired Visas Amid Regional Disruptions
Saudi Arabia’s Online Car Market Accelerates with AI Pricing and Fully Digital Buying Experience
Saudi Arabia Reassesses Defence Strategy as Iranian Drone Threat Drives Shift in Military Partnerships
Drone Strikes Target Saudi Arabia, Kuwait and Bahrain as Regional Conflict Intensifies
Japan and Saudi Arabia Align Efforts to Ease Rising Tensions with Iran
Saudi Crown Prince and Italy’s Meloni Strengthen Strategic Ties in High-Level Talks
SpaceX Explores Potential Five Billion Dollar Investment from Saudi Sovereign Wealth Fund Ahead of IPO
Saudi Arabia Lifts Key Import Barriers to Expand Access for U.S. Beef Exports
Saudi Arabia Enforces Strict Travel Penalties for Visits to Restricted Countries
Italy’s Meloni Embarks on Strategic Gulf Tour to Address Energy Security and Regional Stability
Saudi Film Festival Rescheduled to Summer as Regional Tensions Continue
Saudi Arabia Reports Forty Two Point Six Billion Dollars in Foreign Tourist Spending in 2025
Saudi Crown Prince and Russian President Hold Strategic Call on Escalating Regional Crisis
Saudi Arabia Advances Rail Network as Strategic Alternative to Strait of Hormuz Shipping Route
Ruanyun Edai Launches Saudi Arabia Hub With Forecast of Ten Percent Revenue Growth
Greek Defence Minister Visits Troops in Saudi Arabia Following Successful Missile Interception
Saudi Arabia Expands Global Strategy With Focus on African Critical Minerals
SpaceX Explores Potential Five Billion Dollar Investment From Saudi Fund Ahead of Possible IPO
US Central Command Dismisses Iranian Claim of Mass Casualties Among American Personnel in Saudi Arabia
Co-Diagnostics to Establish Molecular Diagnostics Facility in Saudi Arabia Through Joint Venture
×